986: SGLT-2 INHIBITOR USE IS ASSOCIATED WITH LOWER MORTALITY AND HEPATIC DECOMPENSATION IN PATIENTS WITH MASH CIRRHOSIS AND TYPE 2 DIABETES MELLITUS: A MULTINATIONAL ANALYSIS | Publicación